Authors
Loading...
Diabetics with ACS face higher death/reinfarction rates; extends GUSTO-IIb evidence of consistent hirudin benefit across diabetes status.
Key points are not available for this paper at this time.
Darren K. McGuire (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: